The Survey on Cellular and Engineered Tissue Therapies in Europe in 2013-Reference-Cited by-同舟云学术

The Survey on Cellular and Engineered Tissue Therapies in Europe in 2013

Published:2016-01 Issue:1-2 Volume:22 Page:5-16
ISSN:1937-3341
Container-title:Tissue Engineering Part A
language:en
Short-container-title:Tissue Engineering Part A

Author:

Martin Ivan¹,Ireland Hilary¹,Baldomero Helen²,Dominici Massimo³,Saris Daniël B.⁴,Passweg Jakob²

Affiliation:

1. Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.

2. EBMT Activity Survey Office, University Hospital Basel, Basel, Switzerland.

3. Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University of Modena and Reggio Emilia, Modena Policlinic, Modena, Italy.

4. UMC Utrecht, Orthopaedics, Utrecht, Netherlands.

Publisher

Mary Ann Liebert Inc

Subject

Biomedical Engineering,Biomaterials,Biochemistry,Bioengineering

Link

https://www.liebertpub.com/doi/pdf/10.1089/ten.tea.2015.0416

Reference11 articles.

1. Therapies of the state

2. European Medicines Agency. Guideline on human cell-based medicinal products. EMEA/CHMP/410869/2006. 2008.

3. A Survey on Cellular and Engineered Tissue Therapies in Europe in 2008

4. The Survey on Cellular and Engineered Tissue Therapies in Europe in 2009

5. The Survey on Cellular and Engineered Tissue Therapies in Europe in 2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT);Cytotherapy;2024-07

2. Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review;Stem Cell Research & Therapy;2022-03-04

3. The Survey on Cellular and Tissue-Engineered Therapies in Europe in 2016 and 2017;Tissue Engineering Part A;2021-03-01

4. Cellulosic materials as bioinks for 3D printing applications;Advanced 3D-Printed Systems and Nanosystems for Drug Delivery and Tissue Engineering;2020

5. Additive Manufacturing of Precision Biomaterials;Advanced Materials;2019-08-18